Selecky Christobel
SEC Form 4 insider trading activity
Selecky Christobel has filed 4 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 7, 2026.
On the most recent filing, Selecky Christobel is listed as Director at ImmunityBio, Inc. Inside the rolling window, Selecky Christobel reported no open-market purchases and 6 open-market sales totaling $3.0M in IBRX. The largest disclosed transaction in the window is a sale of 159,478 IBRX shares on Jul 1, 2026, worth $1.4M.
Companies traded
Other insiders at IBRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Selecky Christobel made?
Selecky Christobel has filed 4 SEC Form 4 filings (16 transaction rows) across 1 company since 2026.
Which companies does Selecky Christobel trade?
Selecky Christobel has filed SEC Form 4 disclosures for 1 company, including IBRX.
When was Selecky Christobel's most recent SEC Form 4 filing?
Selecky Christobel's most recent SEC Form 4 filing on Tracefour is dated Jul 7, 2026.
What is Selecky Christobel's total buy and sell value in the current window?
Inside the rolling retention window, Selecky Christobel bought $0 and sold $3.0M based on SEC Form 4 filings.
What was Selecky Christobel's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 159,478 IBRX shares on 2026-07-01, worth $1.4M, per SEC Form 4 filings.